Photo credit: Jan-Joseph Stok Letter Letter | 17 August 2023 HIV/AIDS Open letter to ViiV to improve access to HIV prevention drug CAB-LA 1 min
Letter | 31 July 2023 Tuberculosis Open letter: Requesting clarification from J&J on the recent deal for generic bedaquiline supply
Letter Letter | 13 July 2023 HIV/AIDS Intellectual property and trade Colombia CSO letter supporting Resolution 881/23 by Colombia on issuing a compulsory license for HIV drug dolutegravir
Letter | 11 July 2023 Intellectual property and trade Tuberculosis Belarus Belarus: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis
Letter Letter | 11 July 2023 Intellectual property and trade Tuberculosis Open Letter: Urgent action necessary for equitable access to bedaquiline in all countries with high burdens of TB, MDR-TB, and TB/HIV
Letter Letter | 29 June 2023 Diagnostics HIV/AIDS Open Letters: Civil society calls on Abbott and BD to ensure access to HIV CD4 tests
Letter | 28 February 2023 Tuberculosis Open Letter: Urgent action necessary to improve equitable access to GeneXpert tuberculosis diagnostics and achieve 1/4/6x24
Letter | 06 December 2022 Vaccines The Lancet Gastroenterology & Hepatology: An open letter to Gavi: hepatitis B birth dose vaccine can't wait
